NASDAQ:CME - CME Group Stock Price, Price Target & More

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group declared a quarterly dividend on Tuesday, May 8th. Investors of record on Friday, June 8th will be given a dividend of $0.70 per share on Monday, June 25th. This represents a $2.80 annualized dividend and a dividend yield of 1.66%. The ex-dividend date is Thursday, June 7th. View CME Group's Dividend History.

CME Group Inc (NASDAQ:CME) released its quarterly earnings results on Thursday, April, 26th. The financial services provider reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.01. The financial services provider had revenue of $1.10 billion for the quarter, compared to analysts' expectations of $1.12 billion. CME Group had a net margin of 111.45% and a return on equity of 8.48%. CME Group's revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period last year, the firm earned $1.22 EPS. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for CME Group.

13 brokerages have issued 12 month price targets for CME Group's stock. Their forecasts range from $133.00 to $197.00. On average, they anticipate CME Group's share price to reach $169.5385 in the next twelve months. This suggests a possible upside of 0.4% from the stock's current price. View Analyst Ratings for CME Group.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to CME Group include Intercontinental Exchange (ICE), T. Rowe Price Group (TROW), DEUTSCHE BOERSE/ADR (DBOEY), Nasdaq (NDAQ), Cboe Global Markets (CBOE), LPL Financial (LPLA), BGC Partners (BGCP), INTL Fcstone (INTL), Yintech Investment (YIN), OTC Markets Group (OTCM), National (NHLD) and Primus Guaranty (PRSG).

Media stories about CME stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CME Group earned a daily sentiment score of 0.14 on Accern's scale. They also gave news stories about the financial services provider an impact score of 47.08 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

CME Group's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Pendal Group Ltd (0.20%), KAMES CAPITAL plc (0.15%), Miller Howard Investments Inc. NY (0.13%), Bank of Montreal Can (0.12%), Gateway Investment Advisers LLC (0.07%) and Franklin Street Advisors Inc. NC (0.05%). Company insiders that own CME Group stock include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Phupinder Gill, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Pendal Group Ltd, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Clinton Group Inc., Hartford Investment Management Co., Nippon Life Global Investors Americas Inc., Nisa Investment Advisors LLC and Miller Howard Investments Inc. NY. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Daniel R Glickman, Dennis Suskind, Derek Sammann, Hilda Harris Piell, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME stock was purchased by a variety of institutional investors in the last quarter, including KAMES CAPITAL plc, NN Investment Partners Holdings N.V., Westpac Banking Corp, Cornerstone Wealth Management LLC, State of Alaska Department of Revenue, Chicago Capital LLC, Nadler Financial Group Inc. and Municipal Employees Retirement System of Michigan. View Insider Buying and Selling for CME Group.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CME stock can currently be purchased for approximately $168.86.

CME Group has a market capitalization of $58.05 billion and generates $3.64 billion in revenue each year. The financial services provider earns $4.06 billion in net income (profit) each year or $4.77 on an earnings per share basis. CME Group employs 2,830 workers across the globe.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]